日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epigenetic Regulation of Chromosomal Instability by EZH2 Methyltransferase.

EZH2甲基转移酶对染色体不稳定性进行表观遗传调控。

Bai Yang, Agustinus Albert S, Yomtoubian Shira, Meydan Cem, McNally Dylan R, Yoffe Liron, Hubisz Melissa J, Tranquille Marvel, Pramod Sneha, Hong Christy, Plasilova Magdalena L, Kapoor Aakanksha R, Singh Arshdeep, Withers Henry, Dow Lukas E, Laughney Ashley M, Bhinder Bhavneet, Elemento Olivier, Melnick Ari M, Bakhoum Samuel F, Mittal Vivek

Engineered microRNA scaffolds for potent gene silencing in vivo.

工程化microRNA支架用于体内强效基因沉默

Militello Giuseppe, Greig Alyssa, Bi Chongfeng, Vasileva Ana, Zavodszky Maria I, Lo Shih-Ching, Guilmette Edward, Clarner Pete, Liu Bin, Bhat Guruharsha, Suh Junghae, Dow Lukas, Zuber Johannes, Fellmann Christof, Premsrirut Prem K

Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis

分子动力学驱动胰腺肿瘤发生过程中KRAS突变体表型分化

Grimont, Adrien; Falvo, David J; Sisso, Whitney J; Zumbo, Paul; Chan, Christopher W; Santos, Francisco; Pan, Grace; Cleveland, Megan; Yaron, Tomer M; Osterhoudt, Alexa; Meng, Yinuo; Zafra, Maria Paz; Fall, William B; Rendeiro, Andre F; Hissong, Erika; Yantiss, Rhonda K; Betel, Doron; Magnuson, Mark A; Leach, Steven D; Rustgi, Anil K; Dow, Lukas E; Chandwani, Rohit

Concurrent genetic and non-genetic resistance mechanisms to KRAS inhibition in CRC.

CRC中KRAS抑制剂的遗传和非遗传耐药机制并存

Alonso Salvador, Chu Kevan, Parsons Marie J, Granowsky Elizabeth, Gunasinghe Himari, Shia Jinru, Yaeger Rona, Dow Lukas E

Genetic mechanisms of resistance to targeted KRAS inhibition.

针对KRAS靶向抑制的耐药遗传机制

Diaz Bianca J, Kops Max, Bernardo Sara, Schmidt Henri, Grankowsky Elizabeth, Vega Adrian, Zhang Chen, Bott Matthew, Skamagki Maria, Tomlinson Aidan, Vita Nicole A, Katti Alyna, Labrecque Mark P, Aronchik Ida, Singh Mallika, Dow Lukas E

A potent and selective TNKS2 inhibitor for tumor-selective WNT suppression.

一种强效且选择性的TNKS2抑制剂,用于肿瘤选择性WNT抑制

Zimmerman Jill, Malone Brandon F, Finkin-Groner Efrat, Sun Shan, Liang Rui, Foronda Miguel, Schatoff Emma M, Granowsky Elizabeth, Goswami Sukanya, Katti Alyna, Leach Benjamin, Alcorn Heather, Tammela Tuomas, Fukase Yoshiyuki, Khan Tanweer, Huggins David J, Ginn John, Liverton Nigel, Hite Richard K, Dow Lukas E

Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.

人类胰腺癌中特定 KRAS 突变体的独特临床结果和生物学特征

McIntyre Caitlin A, Grimont Adrien, Park Jiwoon, Meng Yinuo, Sisso Whitney J, Seier Kenneth, Jang Gun Ho, Walch Henry, Aveson Victoria G, Falvo David J, Fall William B, Chan Christopher W, Wenger Andrew, Ecker Brett L, Pulvirenti Alessandra, Gelfer Rebecca, Zafra Maria Paz, Schultz Nikolaus, Park Wungki, O'Reilly Eileen M, Houlihan Shauna L, Alonso Alicia, Hissong Erika, Church George M, Mason Christopher E, Siolas Despina, Notta Faiyaz, Gonen Mithat, Dow Lukas E, Jarnagin William R, Chandwani Rohit

How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research

CRISPR技术如何革新癌症研究新模型的构建

Sánchez Rivera, Francisco J; Dow, Lukas E

Serine Supports Epithelial and Immune Cell Function in Colitis

丝氨酸支持结肠炎中的上皮细胞和免疫细胞功能

Bai, Ji Dong K; Saha, Suchandrima; Wood, Michael C; Chen, Bo; Li, Jinyu; Dow, Lukas E; Montrose, David C

Oncogenic context shapes the fitness landscape of tumor suppression

致癌环境塑造了肿瘤抑制的适应性格局

Blair, Lily M; Juan, Joseph M; Sebastian, Lafia; Tran, Vy B; Nie, Wensheng; Wall, Gregory D; Gerceker, Mehmet; Lai, Ian K; Apilado, Edwin A; Grenot, Gabriel; Amar, David; Foggetti, Giorgia; Do Carmo, Mariana; Ugur, Zeynep; Deng, Debbie; Chenchik, Alex; Paz Zafra, Maria; Dow, Lukas E; Politi, Katerina; MacQuitty, Jonathan J; Petrov, Dmitri A; Winslow, Monte M; Rosen, Michael J; Winters, Ian P